Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances
Eur J Pharmacol. 2024 Feb 26:176452. doi: 10.1016/j.ejphar.2024.176452. Online ahead of print.ABSTRACTSeeking an effective and safe scheme is the common goal of clinical treatment of tumor patients. In recent years, traditional Chinese medicine has attracted more and more attention in order to discover new drugs with good anti-tumor effects. Oroxylin A (OA) is a compound found in natural Oroxylum indicum and Scutellaria baicalensis Georgi plants and has been used in the treatment of various cancers. Studies have shown that OA has a wide range of powerful biological activities and plays an important role in neuroprotection, anti-inflammation, anti-virus, anti-allergy, anti-tumor and so on. OA shows high efficacy in tumor treatment. Therefore, it has attracted great attention of researchers all over the world. This review aims to discuss the anti-tumor effects of OA from the aspects of cell cycle arrest, induction of cell proliferation and apoptosis, induction of autophagy, anti-inflammation, inhibition of glycolysis, angiogenesis, invasion, metastasis and reversal of drug resistance. In addition, the safety and toxicity of the compound were also discussed. As a next step, to clarify the benefits and adverse effects of Oroxylin A in cancer patients further experiments, especially clinical trials, are needed.PMID:38417609 | DOI:10.1016/j.ejphar.2024.176452
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Peng-Xin Wang Xiao-Nan Mu Shu-Hong Huang Kang Hu Zhi-Gang Sun Source Type: research
More News: Allergy | Allergy & Immunology | Brain | Cancer | Cancer & Oncology | Cancer Therapy | China Health | Clinical Trials | Drugs & Pharmacology | Molecular Biology | Neurology | Study | Toxicology